Brief: ABIONYX Pharma H1 Net Income EUR -2.3 Million
25/09/2025 19:16
Sep 25 (Reuters) - ABIONYX Pharma H1 EBIT EUR -2.33 million. H1 operating cash flow EUR -1.7 million
Recent news on Abionyx Pharma SA
See all newsBrief: ABIONYX Pharma And OLON Enter Into Strategic Manufacturing Partnership
France's ABIONYX Pharma H1 net loss widens as financial expenses rise
Brief: ABIONYX Pharma H1 EBIT EUR -2.27 Million
Abionyx jumps as Stifel starts coverage with 'buy'
Cardiovascular drug developer ABIONYX Pharma's H1 revenue falls